ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ - Mollis Shanghai UniClub
|
°¬×̲¡×éºÏÁÆ·¨»ñFDAÔݶ¨Åú×¼ ¡¡¡¡Ò©Ã÷¿µµÂ/±¨µÀ£ºÈÕǰ£¬Mylan¹«Ë¾Ðû²¼ÃÀ¹úFDAͨ¹ý×Üͳ·ÀÖΰ¬×̲¡½ô¼±¾ÈÔ®¼Æ»®(President's Emergency Plan for AIDS Relief, PEPFAR) £¬Ôݶ¨Åú×¼Á˸ù«Ë¾ÎªÓɶàÌæÀΤ(Dolutegravir)¡¢¶÷ÇúËû±õ(Emtricitabine)ºÍÌæÅµ¸£Î¤°¬À·Ó°·(Tenofovir Alafenamide)¹¹³ÉµÄ×éºÏÁÆ·¨µÝ½»µÄÐÂÒ©ÉêÇë¡£ÕâÒ»¿¹Äæ×ªÂ¼²¡¶¾(antiretroviral, ARV)Ò©ÎォÁ¢¼´¿ÉÒÔ±»·¢Õ¹Öйú¼ÒʹÓã¬×÷ΪһÏßÁÆ·¨ÖÎÁư¬×̲¡(AIDS)»¼Õß¡£ ¡¡¡¡¡¾¸£½¨Í¬Ö¾»áËù¡¿°¬×̲¡ÊÇÒ»ÖÖÓÉÓÚ°¬×̲¡¶¾(HIV)¸ÐȾµ¼Öµļ²²¡¡£HIVÄܹ»¹¥»÷ÈËÌåµÄÃâÒßϵͳ£¬ÌرðÊÇTÁܰÍϸ°û¡£Èç¹û²»½ÓÊÜÖÎÁÆ£¬HIV»á¼õÉÙÌåÄÚTϸ°ûµÄÊýÁ¿£¬µ¼ÖÂÈËÌåµÖ¿¹¸ÐȾºÍÆäËü¼²²¡µÄÄÜÁ¦²»¶ÏϽµ¡£Ä¿Ç°ÈÔȻûÓÐÓÐЧµÄÁÆ·¨Äܹ»ÖÎÓú°¬×̲¡£¬µ«ÊÇͨ¹ýÊʵ±µÄÒ½ÁÆ»¤Àí£¬°¬×̲¡¿ÉÒÔ±»¿ØÖÆ¡£Ä¿Ç°ÖÎÁư¬×̲¡µÄÁÆ·¨³ÆÎªARVÁÆ·¨£¬ÕâÖÖÁÆ·¨µÄ³öÏÖÈð¬×̲¡»¼ÕßµÄÊÙÃüÓëûÓиÐȾHIVµÄÈËȺ¼¸ºõÏ൱¡£ ¡¡¡¡´Ë´ÎMylan¹«Ë¾¿ª·¢µÄARV×éºÏÁÆ·¨ÊÇÿÈÕÒ»´Î£¬ÓÉ50ºÁ¿Ë¶àÌæÀΤ£¬200ºÁ¿Ë¶÷ÇúËû±õ£¬ºÍ25ºÁ¿ËÌæÅµ¸£Î¤°¬À·Ó°·¹¹³ÉµÄҩƬ¡£¶àÌæÀΤÊÇViiV Healthcare¹«Ë¾µÄÉÏÊÐÒ©ÎïTivicayµÄÖ÷Òª³É·Ö£¬¶ø¶÷ÇúËû±õºÍÌæÅµ¸£Î¤°¬À·Ó°·ÊÇGilead¹«Ë¾µÄÉÏÊÐÒ©ÎïDescovyµÄÖ÷Òª³É·Ö¡£Mylan¹«Ë¾´ÓҩƷרÀû³Ø(Medicines Patent Pool)ºÍGilead¹«Ë¾»ñµÃÁËÐí¿ÉÉú²úÕâЩҩÎĿǰ£¬ÕâÒ»Ò©Îï×éºÏ±»ÃÀ¹úÎÀÉúºÍ¹«ÖÚ·þÎñ²¿(US Department of Health and Human Services)µÄ°¬×̲¡Ö¸ÄÏÁÐΪ¡°ÖÎÁÆ´ó¶àÊý°¬×̲¡»¼ÕßµÄÍÆ¼öÒ»ÏßÁÆ·¨¡±¡£ ¡¡¡¡¡°FDA¶ÔMylanµÄARV×éºÏÁÆ·¨µÄÔݶ¨Åú׼ΪÄÇЩÊܵ½°¬×̲¡À§ÈÅ×îΪÑÏÖØµÄ¹ú¼ÒµÄ»¼ÕßÃÇÌṩÁ˸üΪÁ®¼ÛµÄÖÎÁÆ·½·¨¡£ÕâÊǵÚÒ»´Î¶àÌæÀΤºÍÌæÅµ¸£Î¤°¬À·Ó°·µÄ×éºÏ³öÏÖÔÚÒ»ÖÖÒ©ÎïÖУ¬¡±Mylan¹«Ë¾µÄÊ×ϯִÐйÙHeather BreschŮʿ˵£¬¡°ÓÉÓÚ×ʽðÓÐÏÞ£¬ÊÀ½çÐèÒª¾¼ÃÓÐЧµÄ°¬×̲¡ÁÆ·¨£¬Mylan¹«Ë¾ºÜ¸ßÐËÄܹ»ÓëºÏ×÷»ï°éÒ»Æð½«ÕâÒ»²úÆ·ÍÆÏòÊг¡²¢ÇÒ°ïÖúÈ«Çò1500ÍòÈÔÈ»ÐèÒª°¬×̲¡ÁÆ·¨µÄ»¼Õß»ñµÃÕâÒ»ÁÆ·¨¡£¡± ¡¡¡¡²Î¿¼×ÊÁÏ£º ¡¡¡¡(1) Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program ¡¡¡¡(2) What are HIV and AIDS? ¡¡¡¡(À´Ô´£ºÒ©Ã÷¿µµÂ) |
Archiver|ÊÖ»ú°æ|СºÚÎÝ|ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ
GMT+8, 2023-1-27 06:41 , Processed in 0.074004 second(s), 18 queries .
© 2001-2013 Comsenz Inc.